News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Breelyn Wilky on botensilimab and balstilimab for refractory sarcomas at ESMO24
Photo taken from Agenus/LinkedIn
Sep 15, 2024, 00:29

Breelyn Wilky on botensilimab and balstilimab for refractory sarcomas at ESMO24

Agenus shared on LinkedIn:

“Breelyn Wilky, presented new data at ESMO24 highlighting the potential of our investigational immunotherapy combination, botensilimab and balstilimab, for treating patients with refractory sarcomas.

Learn more about this advancement.”

Source: Agenus/LinkedIn

Agenus Balstilimab botensilimab Breelyn Wilky cancer ESMO ESMO24 immunotherapy OncoDaily Oncology refractory sarcomas sarcomas
Special Coverage
Blog
Nov 14, 2024, 17:14
Petra Ibum Adjah: Men's Health Matter
Blog
Nov 14, 2024, 16:54
Roupen Odabashian: Looking for medical students or residents interested in conducting AI research in oncology
Blog
Nov 14, 2024, 16:48
ECO is pleased to announce the 16 selected abstracts for the European Cancer Summit 2024
Blog
Nov 14, 2024, 16:45
Oncogene Cancer Research - Success stories like Sally's would not be possible without life-saving research
Blog
Nov 14, 2024, 16:29
Robin Zon: Honored to have been invited as a speaker at COSA
Insight
Nov 14, 2024, 16:27
Jiasen He: Immunotherapy-related neurotoxicity in children with cancer
Insight
Nov 14, 2024, 16:22
Guru P. Sonpavde: Largest analysis of association of irAEs efficacy
Blog
Nov 14, 2024, 16:22
Yara Abdou: Our ASCO editorial on assessing target expression for ADC efficacy
Insight
Nov 14, 2024, 16:13
Aaron Goodman: Hematology Fellow Board Review
Blog
Nov 14, 2024, 16:03
Nicholas Dadarino: The immune landscape of recurrent GBM
Insight
Nov 14, 2024, 15:58
Iván R. González: Warning on Sotorasib Treatment for Advanced Lung Cancer
Insight
Nov 14, 2024, 15:54
Applications for the NKI PhD program are open